AnalystsKemp DolliverKemp Dolliver's Stock Forecasts
AnalystsKemp Dolliver
Analyst Ranking
Bottom 6%
#5042 out of 5342 analysts
Average Return
-26.4%
Win Rate
20%3 out of 15
Risk vs Reward
Poor
Good
Kemp Dolliver's 5 best and worst ratings
Kemp Dolliver Analyst Color
Get additional color on Kemp Dolliver's coverage of popular stocks
Kemp Dolliver's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Verrica Pharmaceuticals IncVRCA | 2 | Strong Buy | $17.00 | +225.67% | Upgrades | 7 months ago |
Radiopharm Theranostics LtdRADX | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | a year ago |
Lisata Therapeutics IncLSTA | 1 | Strong Buy | $32.00 | N/A | Maintains | a year ago |
Y Mabs Therapeutics IncYMAB | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Ibio IncIBIO | 1 | Strong Buy | $3.60 | N/A | Initiates Coverage On | 2 years ago |
Dare Bioscience IncDARE | 1 | Strong Buy | $36.00 | N/A | Upgrades | 2 years ago |
Outlook Therapeutics IncOTLK | 1 | Strong Buy | $31.40 | N/A | Upgrades | 3 years ago |
Point Biopharma Global IncPNT | 1 | Hold | $12.50 | N/A | Downgrades | 3 years ago |
Oncternal Therapeutics IncONCT | 1 | Strong Buy | $40.00 | N/A | Upgrades | 3 years ago |
Lantheus Holdings IncLNTH | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 3 years ago |
Hyperion Defi IncHYPD | 1 | Strong Buy | $640.00 | N/A | Initiates Coverage On | 3 years ago |
Procaps Group SaPROCF | 1 | Hold | $4.50 | N/A | Downgrades | 3 years ago |
Genelux CorpGNLX | 1 | Hold | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Electrocore IncECOR | 1 | Strong Buy | $18.75 | N/A | Initiates Coverage On | 4 years ago |
Edesa Biotech IncEDSA | 1 | Strong Buy | $13.00 | N/A | Maintains | 4 years ago |
Scynexis IncSCYX | 1 | Strong Buy | $64.00 | N/A | Assumes | 4 years ago |
Icecure Medical LtdICCM | 1 | Strong Buy | $169.50 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.